Anticoagulation in heart failure: current status and future direction.

Anticoagulation in heart failure: current status and future direction.

Item
http://www.wikidata.org/entity/Q38044305
Burden and Prevention of Adverse Cardiac Events in Patients with Concomitant Chronic Heart Failure and Coronary Artery Disease: A Literature ReviewDrug target identification using network analysis: Taking active components in Sini decoction as an example.Novel oral anticoagulants and stroke prevention in atrial fibrillation and chronic heart failure.Unmet Needs in Anticoagulant Therapy: Potential Role of Rivaroxaban.Rationale and design of a randomized, double-blind, event-driven, multicentre study comparing the efficacy and safety of oral rivaroxaban with placebo for reducing the risk of death, myocardial infarction or stroke in subjects with heart failure andWarfarin and aspirin for primary prevention in patients with heart failure in sinus rhythmAspirin Does Not Increase Heart Failure Events in Heart Failure Patients: From the WARCEF Trial.Disrupting Virchow's triad: can factor X inhibition reduce risk of adverse outcomes in patients with ischaemic cardiomyopathy?Interactions between cardiovascular and cerebrovascular disease
P2860

Anticoagulation in heart failure: current status and future direction.

Item
http://www.wikidata.org/entity/Q38044305
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
Anticoagulation in heart failure: current status and future direction.
@en
type
label
Anticoagulation in heart failure: current status and future direction.
@en
prefLabel
Anticoagulation in heart failure: current status and future direction.
@en
P1433
P1476
P2093
P2860
P2888
P304
P31
P356
P433
P478
P50
P577
P5875
P698
P921
P356
P1433
P1476
Anticoagulation in heart failure: current status and future direction.
@en
P2093
P2860
P2888
P304
P31
P356
P433
P478
P50
P577
P5875
P698
P921